Steven Oliveira
President at Oliveira Capital LLC
Net worth: 343 569 $ as of 31/05/2024
Profile
Steven M.
Oliveira is the founder of SIGA Technologies, Inc. founded in 1995.
He is also the founder of Assertio Therapeutics, Inc. Mr. Oliveira's current job is President at Oliveira Capital LLC since 2002.
Mr. Oliveira's former jobs include Director at Repros Therapeutics, Inc., Director at Ideanomics, Inc. from 2010 to 2011, Independent Director at Pulte Acquisition Corp., Chief Investment Officer at Chardan SPAC Asset Management LLC from 2008 to 2013, and Managing Partner at CSO Ventures.
Mr. Oliveira received his undergraduate degree from Manhattan College in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BENITEC BIOPHARMA INC
0.48% | 22/04/2024 | 44,911 ( 0.48% ) | 343 569 $ | 31/05/2024 |
Steven Oliveira active positions
| Companies | Position | Start |
|---|---|---|
| Oliveira Capital LLC | President | 01/01/2002 |
Former positions of Steven Oliveira
| Companies | Position | End |
|---|---|---|
| Chardan SPAC Asset Management LLC | Chief Investment Officer | 01/01/2013 |
| IDEANOMICS, INC. | Director/Board Member | 30/03/2011 |
| REPROS THERAPEUTICS INC | Director/Board Member | - |
| SIGA TECHNOLOGIES, INC. | Founder | - |
| CSO Ventures | Corporate Officer/Principal | - |
Training of Steven Oliveira
| Manhattan College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IDEANOMICS, INC. | Consumer Durables |
| SIGA TECHNOLOGIES, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Pulte Acquisition Corp.
 Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL. | Miscellaneous |
| Oliveira Capital LLC | |
| Chardan SPAC Asset Management LLC | |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| CSO Ventures | |
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
- Stock Market
- Insiders
- Steven Oliveira
